Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer

Jung Eun Shin, Su Hyung Park, Yeun Kyu Jang

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The interleukin 6 family of cytokines including leukemia inhibitory factor (LIF) regulates the progression of several types of cancer. However, although LIF overexpression during breast cancer progression was observed in our previous report, the molecular mechanisms responsible for this deregulation remain largely unknown. Here we show that LIF expression is epigenetically up-regulated via DNA demethylation and changes in histone methylation status within its promoter region in the isogenic MCF10 model. Bisulfite sequencing revealed the CpG pairs within the promoter region are hypermethylated in normal breast epithelial cells, but extensively demethylated as breast cancer progresses. In agreement with the DNA methylation pattern, our chromatin immunoprecipitation showed that inactive epigenetic marks such as MeCP2 occupancy and histone H3-Lys9-dimethylation significantly decreased during the progression to breast cancer but an active histone mark was increased in an inverse manner. Also, the occupancy of the transcription factor Sp1, which has higher affinity for hypomethylated CpGs, increased. RNAimediated knockdown of LIF expression resulted in a significant reduction of cell growth and colony formation in breast cancer cells, suggesting the potential role of LIF-LIF receptor axis in autocrine stimulation of cancer cells. Collectively, our data suggest that the epigenetic up-regulation of the LIF gene likely play an important role in the development of breast cancer.

Original languageEnglish
Pages (from-to)181-189
Number of pages9
JournalMolecules and cells
Volume31
Issue number2
DOIs
Publication statusPublished - 2011 Feb 1

Fingerprint

Leukemia Inhibitory Factor
Epigenomics
Up-Regulation
Breast Neoplasms
Genes
Genetic Promoter Regions
Histones
Histone Code
OSM-LIF Receptors
Sp1 Transcription Factor
Chromatin Immunoprecipitation
DNA Methylation
Methylation
Interleukin-6
Neoplasms
Breast
Epithelial Cells
Cytokines
DNA
Growth

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cell Biology

Cite this

@article{1e68e073d4a14c3ab8bd0e7d6e971ec2,
title = "Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer",
abstract = "The interleukin 6 family of cytokines including leukemia inhibitory factor (LIF) regulates the progression of several types of cancer. However, although LIF overexpression during breast cancer progression was observed in our previous report, the molecular mechanisms responsible for this deregulation remain largely unknown. Here we show that LIF expression is epigenetically up-regulated via DNA demethylation and changes in histone methylation status within its promoter region in the isogenic MCF10 model. Bisulfite sequencing revealed the CpG pairs within the promoter region are hypermethylated in normal breast epithelial cells, but extensively demethylated as breast cancer progresses. In agreement with the DNA methylation pattern, our chromatin immunoprecipitation showed that inactive epigenetic marks such as MeCP2 occupancy and histone H3-Lys9-dimethylation significantly decreased during the progression to breast cancer but an active histone mark was increased in an inverse manner. Also, the occupancy of the transcription factor Sp1, which has higher affinity for hypomethylated CpGs, increased. RNAimediated knockdown of LIF expression resulted in a significant reduction of cell growth and colony formation in breast cancer cells, suggesting the potential role of LIF-LIF receptor axis in autocrine stimulation of cancer cells. Collectively, our data suggest that the epigenetic up-regulation of the LIF gene likely play an important role in the development of breast cancer.",
author = "Shin, {Jung Eun} and Park, {Su Hyung} and Jang, {Yeun Kyu}",
year = "2011",
month = "2",
day = "1",
doi = "10.1007/s10059-011-0020-z",
language = "English",
volume = "31",
pages = "181--189",
journal = "Molecules and Cells",
issn = "1016-8478",
publisher = "Korean Society for Molecular and Cellular Biology",
number = "2",

}

Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer. / Shin, Jung Eun; Park, Su Hyung; Jang, Yeun Kyu.

In: Molecules and cells, Vol. 31, No. 2, 01.02.2011, p. 181-189.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer

AU - Shin, Jung Eun

AU - Park, Su Hyung

AU - Jang, Yeun Kyu

PY - 2011/2/1

Y1 - 2011/2/1

N2 - The interleukin 6 family of cytokines including leukemia inhibitory factor (LIF) regulates the progression of several types of cancer. However, although LIF overexpression during breast cancer progression was observed in our previous report, the molecular mechanisms responsible for this deregulation remain largely unknown. Here we show that LIF expression is epigenetically up-regulated via DNA demethylation and changes in histone methylation status within its promoter region in the isogenic MCF10 model. Bisulfite sequencing revealed the CpG pairs within the promoter region are hypermethylated in normal breast epithelial cells, but extensively demethylated as breast cancer progresses. In agreement with the DNA methylation pattern, our chromatin immunoprecipitation showed that inactive epigenetic marks such as MeCP2 occupancy and histone H3-Lys9-dimethylation significantly decreased during the progression to breast cancer but an active histone mark was increased in an inverse manner. Also, the occupancy of the transcription factor Sp1, which has higher affinity for hypomethylated CpGs, increased. RNAimediated knockdown of LIF expression resulted in a significant reduction of cell growth and colony formation in breast cancer cells, suggesting the potential role of LIF-LIF receptor axis in autocrine stimulation of cancer cells. Collectively, our data suggest that the epigenetic up-regulation of the LIF gene likely play an important role in the development of breast cancer.

AB - The interleukin 6 family of cytokines including leukemia inhibitory factor (LIF) regulates the progression of several types of cancer. However, although LIF overexpression during breast cancer progression was observed in our previous report, the molecular mechanisms responsible for this deregulation remain largely unknown. Here we show that LIF expression is epigenetically up-regulated via DNA demethylation and changes in histone methylation status within its promoter region in the isogenic MCF10 model. Bisulfite sequencing revealed the CpG pairs within the promoter region are hypermethylated in normal breast epithelial cells, but extensively demethylated as breast cancer progresses. In agreement with the DNA methylation pattern, our chromatin immunoprecipitation showed that inactive epigenetic marks such as MeCP2 occupancy and histone H3-Lys9-dimethylation significantly decreased during the progression to breast cancer but an active histone mark was increased in an inverse manner. Also, the occupancy of the transcription factor Sp1, which has higher affinity for hypomethylated CpGs, increased. RNAimediated knockdown of LIF expression resulted in a significant reduction of cell growth and colony formation in breast cancer cells, suggesting the potential role of LIF-LIF receptor axis in autocrine stimulation of cancer cells. Collectively, our data suggest that the epigenetic up-regulation of the LIF gene likely play an important role in the development of breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=79952991241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952991241&partnerID=8YFLogxK

U2 - 10.1007/s10059-011-0020-z

DO - 10.1007/s10059-011-0020-z

M3 - Article

C2 - 21191816

AN - SCOPUS:79952991241

VL - 31

SP - 181

EP - 189

JO - Molecules and Cells

JF - Molecules and Cells

SN - 1016-8478

IS - 2

ER -